Mymetics Corp (MYMX): PCI Biotech placed a patent application...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: castaways post# 27425

Thursday, 05/18/2023 12:26:04 PM

Thursday, May 18, 2023 12:26:04 PM

PCI Biotech placed a patent application for an undisclosed treatment approach involving fimaVacc that was filed in Q1 2023.

No confirmation of MYMX involvement but the timeline fits.

12 May 2023.

https://www.globenewswire.com/news-release/2023/05/12/2667502/0/en/PCI-Biotech-interim-Q1-2023-results.html

https://www.mymetics.com/media-center/mymetics-and-pci-biotech-sign-preclinical-research-collaboration/

Keep Last Read

Replies (1) Next 10 Prev Next

Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM

InvestorsHub NewsWire

Only $200 per official company press release!